Advertisement

Diabetic Retinopathy

  • Authors
  • S.┬áRiaskoff

Table of contents

About this book

Introduction

The evaluation of diabetic retinopathy is often difficult, because the clinical picture is complex due to the mUltiplicity of symptoms. Omission of treatment by photocoagulation at the right moment may have grave consequences. Forthe evaluation of diabetic retinopathy we have to estimate first the developmental degree of each symptom and secondly we have to estimate what the natural history of each particular retinopathy will be. There exists a number of classification systems, into the frame of which the clinical picture of diabetic retinopathy can be placed. Without entering into the details of these systems we want to mention that our classification has been developed from the method of Oakley and the classification model conceived at the Airlie House meeting in 1968. The essence of this classification is that standard pictures are used for the estimation of the developmental degree of the different symptoms in diabetic retinopathy. In our classification we use for each symptom two standard photographs instead of one, as originally proposed at the Airlie House meeting. (1,2). Standard photograph number one stands for the moderate (grade 1 ) manifestation and standard photograph numbertwo stands forthe marked (grade 2) manifestation of the symptom. Ifthe manifestation ofthe sympton is less marked than in standard photograph one, it is referred to as < 1 ; if it is more marked than in standard photograph two, it is referred to as > 2.

Keywords

aneurysm classification development diabetes evaluation proliferation retina tissue treatment

Bibliographic information

  • DOI https://doi.org/10.1007/978-94-010-1581-3
  • Copyright Information Springer Science+Business Media B.V. 1976
  • Publisher Name Springer, Dordrecht
  • eBook Packages Springer Book Archive
  • Print ISBN 978-90-6193-554-4
  • Online ISBN 978-94-010-1581-3
  • Buy this book on publisher's site
Industry Sectors
Pharma
Health & Hospitals
Biotechnology